Celldex Therapeutics Inc (CLDX)
Equity Ratio
91.34%
Quarterly · Period ending:
CLDX Equity Ratio
Latest reported91.34%period ending
Latest reported91.34%period ending
CLDX Quarterly Equity Ratio (-78.13% → 91.34%)
Latest values, visible window
High-resolution chart · PNG
CLDX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 91.3357% | |
| 89.2367% | |
| 90.4254% | |
| 92.2775% | |
| 94.6562% | |
| 95.0654% | |
| 94.2783% | |
| 95.4719% | |
| 96.2243% | |
| 96.5202% | |
| 92.1706% | |
| 88.0331% | |
| 92.7253% | |
| 93.2888% | |
| 92.4785% | |
| 93.5514% | |
| 90.6026% | |
| 93.8827% | |
| 94.3376% | |
| 94.8959% | |
| 89.1132% | |
| 88.634% | |
| 88.7715% | |
| 89.9148% | |
| 91.2177% | |
| 74.4% | |
| 76.4856% | |
| 76.8957% | |
| 77.069% | |
| 76.3622% | |
| 79.6231% | |
| 76.1402% | |
| 71.7845% | |
| 70.0621% | |
| 74.8894% | |
| 68.6098% | |
| 66.8814% | |
| 68.8342% | |
| 69.2384% | |
| 86.1657% | |
| 86.5427% | |
| 86.123% | |
| 85.9356% | |
| 90.3568% | |
| 90.2564% | |
| 92.1148% | |
| 85.342% | |
| 88.1129% | |
| 89.1539% | |
| 91.5742% | |
| 92.1347% | |
| 86.621% | |
| 90.2468% | |
| 86.8857% | |
| 76.289% | |
| 75.949% | |
| 77.4165% | |
| 78.8986% | |
| 70.1288% | |
| 74.3896% | |
| 77.6571% | |
| 71.1928% | |
| 68.4491% | |
| 46.5267% | |
| 49.3555% | |
| 51.6886% | |
| 52.5541% | |
| -4.6568% | |
| 7.9082% | |
| 18.5723% | |
| 25.982% | |
| 30.1036% | |
| 34.0888% | |
| 69.0205% | |
| -50.5828% | |
| -32.1316% | |
| -17.9468% | |
| -6.1915% | |
| 3.515% | |
| 12.0204% | |
| 18.6711% | |
| 24.811% | |
| 57.306% | |
| 61.6213% | |
| 65.312% | |
| 83.7911% | |
| 83.8532% | |
| 90.994% | |
| 93.1916% | |
| 94.3797% | |
| 89.1858% | |
| 90.7642% | |
| 85.856% | |
| 87.1327% | |
| 88.9627% | |
| 90.2378% | |
| 83.3485% | |
| 84.6306% | |
| 84.6388% | |
| 82.7427% |